Health Care & Life Sciences » Pharmaceuticals | Shanghai Kaibao Pharmaceutical Co. Ltd.

Shanghai Kaibao Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
864
1,007
1,026
1,095
1,181
1,228
Total Accounts Receivable
427
540
685
639
710
741
Inventories
101
108
179
173
182
173
Other Current Assets
20
64
27
15
29
18
Total Current Assets
1,412
1,719
1,918
1,923
2,102
2,160
Net Property, Plant & Equipment
313
347
401
373
374
353
Total Investments and Advances
-
-
56
181
154
182
Intangible Assets
42
47
47
45
44
42
Other Assets
-
-
1
1
1
-
Total Assets
1,771
2,117
2,427
2,528
2,680
2,747
ST Debt & Current Portion LT Debt
-
-
54
29
16
Accounts Payable
19
39
87
61
61
Income Tax Payable
17
21
17
10
6
Other Current Liabilities
106
151
217
188
197
Total Current Liabilities
142
211
376
287
279
Deferred Taxes
3
4
4
5
5
Other Liabilities
-
-
20
18
16
Total Liabilities
142
211
396
304
295
Common Equity (Total)
1,606
1,885
2,006
2,200
2,365
Total Shareholders' Equity
1,606
1,885
2,006
2,200
2,365
Total Equity
1,606
1,885
2,006
2,200
2,365
Liabilities & Shareholders' Equity
1,771
2,117
2,427
2,528
2,680
Non-Equity Reserves
23
22
25
23
19

About Shanghai Kaibao Pharmaceutical Co.

View Profile
Address
No. 88, Chengpu Road
Shanghai Shanghai 201401
China
Employees -
Website http://www.xykb.com
Updated 07/08/2019
Shanghai Kaibao Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of modern Chinese medicine. Its medicines are in the form of injection, tablets, hard capsules, granules, mixture, syrup, oral liquid, and Chinese medicine extraction; such as Tanreqing injection, doxofylline capsule, Captopril sustained-release tablets, and Hydrochloride pioglitazone tablets. The company was founded on April 12, 2000 and is headquartered in Shanghai, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.